BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37171773)

  • 1. Integrative Analysis of Core Genes and Biological Process Involved in Polycystic Ovary Syndrome.
    Zhang Y; Zhao T; Hu L; Xue J
    Reprod Sci; 2023 Oct; 30(10):3055-3070. PubMed ID: 37171773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
    Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
    Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of ferroptosis-related genes in granulosa cells associates with impaired oocyte quality in polycystic ovary syndrome.
    Huang J; Fan H; Li C; Yang K; Xiong C; Xiong S; Feng S; Chen S; Wang B; Su Y; Xu B; Yang H; Wang N; Zhu J
    Front Endocrinol (Lausanne); 2024; 15():1346842. PubMed ID: 38390208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis.
    Bi X; Zhai Z; Wang S
    Gen Physiol Biophys; 2019 May; 38(3):205-214. PubMed ID: 31184307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis.
    Zhang T; Liu Y; Li X; Hu B
    Comb Chem High Throughput Screen; 2023; 26(1):126-134. PubMed ID: 35379124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
    Liu Y; Yu J; Li J; Li W; Ma H
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
    Qiao G; Xing J; Luo X; Zhang C; Yi J
    Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.
    Shen H; Liang Z; Zheng S; Li X
    Int J Mol Med; 2017 Nov; 40(5):1385-1396. PubMed ID: 28949383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in China.
    Li Q; Sang Y; Chen Q; Ye B; Zhou X; Zhu Y
    J Ovarian Res; 2023 Aug; 16(1):154. PubMed ID: 37537636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
    Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
    BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
    Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
    Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of senescence-related genes in polycystic ovary syndrome.
    Jiang D; Xu Y; Yang L; Li P; Han X; Li Q; Yang Y; Chao L
    J Ovarian Res; 2024 Jan; 17(1):7. PubMed ID: 38184636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis.
    Yang D; Li N; Ma A; Dai F; Zheng Y; Hu X; Wang Y; Xian S; Zhang L; Yuan M; Liu S; Deng Z; Yang Y; Cheng Y
    Reprod Sci; 2021 May; 28(5):1353-1361. PubMed ID: 33067753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.
    Huang J; Huang B; Kong Y; Yang Y; Tian C; Chen L; Liao Y; Ma L
    Front Endocrinol (Lausanne); 2022; 13():1032064. PubMed ID: 36523600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
    Wei L; Xin C; Wang W; Hao C
    Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of ferroptosis-related genes with the pathogenesis in polycystic ovary syndrome.
    Lin S; Jin X; Gu H; Bi F
    Front Med (Lausanne); 2023; 10():1120693. PubMed ID: 36873892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor‑microRNA synergistic regulatory network revealing the mechanism of polycystic ovary syndrome.
    Liu HY; Huang YL; Liu JQ; Huang Q
    Mol Med Rep; 2016 May; 13(5):3920-8. PubMed ID: 27035648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
    Liu L; He D; Wang Y; Sheng M
    Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of hub genes involved in PCOS using biological informatics methods.
    Zhou F; Xing Y; Cheng T; Yang L; Ma H
    Medicine (Baltimore); 2022 Oct; 101(40):e30905. PubMed ID: 36221354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses.
    Zhang J; Zhang FJ; Zhang L; Xian DX; Wang SA; Peng M; Liu Y
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3255-3269. PubMed ID: 37140276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.